Doxorubicin Other names: Doxorubicin hydrochloride

Chemical formula: C₂₇H₂₉NO₁₁  Molecular mass: 543.519 g/mol  PubChem compound: 31703

Active ingredient description

Doxorubicin is a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius. The exact mechanism of the antitumour activity of doxorubicin is not known. It is generally believed that inhibition of DNA, RNA and protein synthesis is responsible for the majority of the cytotoxic effects.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
L01DB01 Doxorubicin L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
CAELYX Concentrate for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC
ADRIAMYCIN Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
DOXORUBICIN Concentrate for solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 23214-92-8
CAS Substance: 25316-40-9
DrugBank Drug: DB00997
KEGG Drug: D03899
PubChem Compound: 31703
RxNorm Ingredient: 3639
SNOMED-CT Concept: 372817009
Doxorubicin (substance)
UNII Identifier: 80168379AG
DOXORUBICIN

Medicines

Doxorubicin is an active ingredient of these brands:

United States (US)

  • ADRIAMYCIN as DOXORUBICIN HYDROCHLORIDE
  • DOXIL as DOXORUBICIN HYDROCHLORIDE

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

  • CAELYX as DOXORUBICIN HYDROCHLORIDE

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

  • DOXOCRIS as DOXORUBICIN HYDROCHLORIDE
  • DOXOPEG as DOXORUBICIN HYDROCHLORIDE
  • DOXTIE as DOXORUBICIN HYDROCHLORIDE
  • GRANA as DOXORUBICIN HYDROCHLORIDE
  • NUDOXA as DOXORUBICIN HYDROCHLORIDE
  • VARIDOXO as DOXORUBICIN HYDROCHLORIDE

Estonia (EE)

Finland (FI)

  • CAELYX as DOXORUBICIN HYDROCHLORIDE
  • MYOCET as DOXORUBICIN HYDROCHLORIDE

France (FR)

  • ADRIBLASTINE as DOXORUBICIN HYDROCHLORIDE
  • CAELYX as DOXORUBICIN HYDROCHLORIDE
  • MYOCET as DOXORUBICIN HYDROCHLORIDE
  • ZOLSKETIL as Doxorubicin hydrochloride in a pegylated liposomal formulation

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

  • CAELYX as DOXORUBICIN HYDROCHLORIDE
  • LIPODOX as DOXORUBICIN HYDROCHLORIDE

Italy (IT)

Japan (JP)

  • ADRIACIN as DOXORUBICIN HYDROCHLORIDE
  • DOXIL as DOXORUBICIN HYDROCHLORIDE

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

  • CAELYX as DOXORUBICIN HYDROCHLORIDE
  • MYOCET as DOXORUBICIN HYDROCHLORIDE

New Zealand (NZ)

Nigeria (NG)

  • CAELYX as DOXORUBICIN HYDROCHLORIDE

Poland (PL)

Romania (RO)

  • CAELYX as DOXORUBICIN HYDROCHLORIDE
  • MYOCET as DOXORUBICIN HYDROCHLORIDE
  • ZOLSKETIL as Doxorubicin hydrochloride in a pegylated liposomal formulation

Singapore (SG)

  • ADRIAMYCIN as DOXORUBICIN HYDROCHLORIDE
  • ADRIM as DOXORUBICIN HYDROCHLORIDE
  • CAELYX as DOXORUBICIN HYDROCHLORIDE
  • DIOX as DOXORUBICIN HYDROCHLORIDE
  • DOXABIN as DOXORUBICIN HYDROCHLORIDE
  • EBEDOXO as DOXORUBICIN HYDROCHLORIDE

South Africa (ZA)

Spain (ES)

  • CAELYX as DOXORUBICIN HYDROCHLORIDE
  • FARMIBLASTINA as DOXORUBICIN HYDROCHLORIDE
  • MYOCET as DOXORUBICIN HYDROCHLORIDE
  • ZOLSKETIL as Doxorubicin hydrochloride in a pegylated liposomal formulation

Tunisia (TN)

Turkey (TR)

  • ADRIMISIN as DOXORUBICIN HYDROCHLORIDE
  • CAELYX as DOXORUBICIN HYDROCHLORIDE
  • DOXTU as DOXORUBICIN HYDROCHLORIDE

United Kingdom (UK)

  • CAELYX as DOXORUBICIN HYDROCHLORIDE

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.